(Reuters) – SoftBank Group Corp will invest $900 million in gene sequencing firm Pacific Biosciences of California Inc in its latest healthcare investment, the company said on Wednesday.
(Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli)
